Improving the effectiveness of immunotherapy for glioblastoma
Researchers utilised AI to identify genes that reprogramme GBM cancer cells into dendritic cells within the tumour.
List view / Grid view
Researchers utilised AI to identify genes that reprogramme GBM cancer cells into dendritic cells within the tumour.
A new drug could replace the current standard for treating radioresistance brain cancer by sensitising the cancer cells to radiotherapy.
US researchers develop a dual-action cell therapy engineered to eliminate established tumours and train the immune system to eradicate primary tumour and prevent cancer’s recurrence.
A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.